Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P155 - ESOC25-1333 MOLECULAR BIOMARKERS IN CEREBRAL AMYLOID ANGIOPATHY WITH AND WITHOUT SYMPTOMATIC INTRACEREBRAL HAEMORRHAGE Benedetta Storti *1 , Alessandro Francia 1,2 , Giulia Marinoni 1 , Benedetta Cefaloni 3 , Nicola Rifino 1 , Giorgio Boncoraglio 1 , Antonio Indaco 4 , Giuseppe Di Fede 4 , Mario Stanziano 5 , Isabella Canavero 1 , Anna Bersano 1 1 Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, 2 Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy, 3 Dipartimento di Matematica, Politecnico di Milano, Milan, Italy, 4 Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, 5 Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy Background and Aims: Cerebral amyloid angiopathy (CAA) typically presents as lobar intracerebral haemorrhage (ICH) or cognitive impairment
This treatment is derived from natural sources, which lowers the risk of side effects
Some users also introduce AOD-9604 during the early phase of Retatrutide dose escalation to give fat loss a head start while Retatrutide builds to its full therapeutic dose
Central Command 05:34 Trump calls for new election security measures 02:01 Special Report: Trump delivers speech on White House declassification of election documents 32:39 Special Report: Trump delivers speech on election infrastructure 06:14 WH teleprompter operator on leave for alleged insider trading on Trump's speeches 02:41 Trump teleprompter operator betting allegations 01:36 Truth Social plans to sell Wall Street firms 'fast' access to president's posts 03:09 Trump reverses DHS order for ICE officers 00:59 Trump says he will back off plan to toll ships in Strait of Hormuz 07:23 Trump calls late Sen
However, this side effect is not common and can be minimized by consulting with your physician on prescribing right injection dose
